These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 3316060

  • 21. [Ceftazidime in pneumology].
    Bariffi F, Giacomelli P, Sanduzzi A.
    G Ital Chemioter; 1985; 32(2):403-10. PubMed ID: 3914432
    [No Abstract] [Full Text] [Related]

  • 22. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants].
    Bégué P, Michel B, Chasalette JP, Allouche G, Quinet B.
    Pathol Biol (Paris); 1986 May; 34(5):525-9. PubMed ID: 3534737
    [Abstract] [Full Text] [Related]

  • 23. Clinical experience with ceftazidime for lower respiratory tract infections.
    De Sandre G, Corrocher RI, Gabrielli GB, Ho I.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():307-10. PubMed ID: 19803004
    [No Abstract] [Full Text] [Related]

  • 24. [Report of experiences with the oral cephalosporin-derivative cephaclor in respiratory tract infections].
    Spath P.
    Wien Med Wochenschr; 1983 Jan 15; 133(1):27-30. PubMed ID: 6837048
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic and prophylactic effects of cephalexin and bromhexine in respiratory tract complications of abdominal surgery.
    Palmieri B, Monni S, Misella A, Cogni P.
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar 15; 21(3):143-6. PubMed ID: 6853000
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Open clinical trial of roxithromycin amongst patients of Jos University Teaching Hospital with lower and upper respiratory tract infections.
    Idoko JA, Anteyi EA, Ighogboja IS, Ikeh EI.
    West Afr J Med; 1995 Mar 15; 14(3):127-33. PubMed ID: 8519697
    [Abstract] [Full Text] [Related]

  • 29. Clinical experience in the treatment of lower respiratory tract infections with ceftazidime.
    Pettersson T, Ahvonen P, Storgårds E.
    J Antimicrob Chemother; 1981 Sep 15; 8 Suppl B():303-5. PubMed ID: 19803003
    [Abstract] [Full Text] [Related]

  • 30. [Ciprofloxacin: a new fluoroquinolone for the treatment of respiratory tract infections].
    Scarlini GF, Germani M, Martino M, Perna R.
    Minerva Med; 1991 May 15; 82(5):293-9. PubMed ID: 2041620
    [Abstract] [Full Text] [Related]

  • 31. [Preliminary clinical studies on the efficacy and tolerance of kanendomycin in the pneumological field].
    Moreo GC, Comaschi GF.
    G Ital Chemioter; 1976 May 15; 23(1):11-6. PubMed ID: 800999
    [No Abstract] [Full Text] [Related]

  • 32. [Serum drug levels and drug efficacy--antibiotics].
    Kohno S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jan 15; 25(1):38-43. PubMed ID: 3298765
    [No Abstract] [Full Text] [Related]

  • 33. Trial of ceftazidime efficacy in respiratory infections at two dose levels.
    Feist H, Vetter N, Muhar F, Williams KJ, Brandstetter HJ, Ho I.
    J Antimicrob Chemother; 1981 Sep 15; 8 Suppl B():299-301. PubMed ID: 19803002
    [Abstract] [Full Text] [Related]

  • 34. Aztreonam and ceftazidime: evidence of in vivo cross allergenicity.
    Pérez Pimiento A, Gómez Martínez M, Mínguez Mena A, Trampal González A, de Paz Arranz S, Rodríguez Mosquera M.
    Allergy; 1998 Jun 15; 53(6):624-5. PubMed ID: 9689350
    [No Abstract] [Full Text] [Related]

  • 35. The optimal dosage of ceftazidime for severe lower respiratory tract infections.
    Cade JF, Presneill J, Sinickas V, Hellyar A.
    J Antimicrob Chemother; 1993 Oct 15; 32(4):611-22. PubMed ID: 8288503
    [Abstract] [Full Text] [Related]

  • 36. Studies on a new formulation of ceftazidime--ceftazidime arginine--in patients with recurrent chest infections.
    Davies BI, Maesen FP, Baur C, Evers WB.
    J Antimicrob Chemother; 1987 Jul 15; 20(1):133-6. PubMed ID: 3305461
    [Abstract] [Full Text] [Related]

  • 37. Ceftazidime versus placebo in respiratory exacerbations of cystic fibrosis.
    Weston B, MacMillan JP.
    J Pediatr; 1988 Sep 15; 113(3):618. PubMed ID: 3045285
    [No Abstract] [Full Text] [Related]

  • 38. [Comparative clinical study of ceftazidime and cefotiam for respiratory tract infections by a double-blind method].
    Hara K, Saito A, Yamaguchi K, Suzuyama Y, Shigeno Y, Nakamura I, Oda T, Okuno K, Iwasaki H, Saito A.
    Kansenshogaku Zasshi; 1984 Jul 15; 58(7):663-702. PubMed ID: 6096454
    [No Abstract] [Full Text] [Related]

  • 39. [[Multicenter comparative study of meropenem, a new carbapenemic preparation, administered intramuscularly. Treatment of respiratory and urinary infections in hospitalized patients]l].
    Lechi A, Montesi G.
    Clin Ter; 1995 Jan 15; 146(1):31-47. PubMed ID: 7705012
    [Abstract] [Full Text] [Related]

  • 40. Sequential intravenous/oral ciprofloxacin compared with intravenous ceftazidime in the treatment of serious lower respiratory tract infections.
    Menon L, Ernst JA, Sy ER, Flores D, Pacia A, Lorian V.
    Am J Med; 1989 Nov 30; 87(5A):119S-120S. PubMed ID: 2686412
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.